I. Wynter

发表

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

H. H. Jensen, P. Wilding, S. Pocock, 2017, The Lancet.

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke ( RIGHT-2 ) : an ambulance-based , randomised , sham-controlled , blinded , phase 3 trial

Peter J. Godolphin, P. Sandercock, C. Anderson, 2019 .

Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial.

G. Lip, S. Lewis, R. Wilcox, 2021, The Lancet. Neurology.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Patricia A. H. Williams, Steve B Jones, K. Y. Wong, 2021, The Lancet.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, Johshua N. Fletcher, 2019, The Lancet. Neurology.

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study

M. Power, D. Werring, H. Jäger, 2018, The Lancet Neurology.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, M. Dennis, 2019, Lancet.

Effects of fluoxetine on functional outcomes after acute stroke ( FOCUS ) : a pragmatic , double blind , randomised , controlled

Joshua R. Smith, Ashutosh Kumar Singh, Stephen H. Levy, 2019 .

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Paul J. Harrison, Gary F. Simons, A. L. Tan, 2023, The Lancet Regional Health - Europe.

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

Gary F. Simons, A. L. Tan, L. Wain, 2023, eClinicalMedicine.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

Fluid Optimisation in Emergency Laparotomy (FLO-ELA) Trial: study protocol for a multi-centre randomised trial of cardiac output-guided fluid therapy compared to usual care in patients undergoing major emergency gastrointestinal surgery

Grant T. Gibson, Peter D. Campbell, Thomas W. Judd, 2023, Trials.

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Matthew A. Wiles, Ellen C. Smith, Jack D. Sanders, 2023, Nature.

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Matthew A. Wiles, Ellen C. Smith, Jack D. Sanders, 2023, Nature.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

P. Sandercock, C. Anderson, P. Rothwell, 2019, Lancet.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Paul J. Harrison, Gary F. Simons, A. L. Tan, 2023, The Lancet Respiratory Medicine.

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Paul J. Harrison, Jennifer M. Brown, Gary F. Simons, 2022, The Lancet. Respiratory medicine.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

C. Sudlow, P. Sandercock, D. Werring, 2018, Trials.

Peer Review File Manuscript Title: Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19 Reviewer Comments & Author Rebuttals

Mohammed A. Eid, Daniel J. Wilson, Nathan D. Berkowitz, 2022 .

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

K. Y. Wong, Mohammad A. Qayum, John S. Clouston, 2022, Lancet.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

K. Y. Wong, Beverley E. Crane, Scott M Elliott, 2021, Lancet.

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Panteleimon G. Takis, Jordan J. Clark, Michael J. Murphy, 2022, eBioMedicine.

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Thomas E. Nichols, Paul J. Harrison, Jennifer M. Brown, 2023, The Lancet. Respiratory medicine.

Whole-genome sequencing reveals host factors underlying critical COVID-19

Eurie L. Hong, Mohammed A. Eid, Daniel J. Wilson, 2022, Nature.

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Patricia A. H. Williams, K. Y. Wong, Ayesha Binte Ashfaq, 2021, Lancet.

Stratified analyses refine association between TLR7 rare variants and severe COVID-19

K. Rawlik, N. Sacchi, N. Love, 2024, HGG advances.